/
/
/

Accretion Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%

Share Price Live Stats

Open (₹)205.00
Volume (₹)12,000.00
High (₹)206.40
Upper Circuit215.15
Low (₹)201.20
Lower Circuit194.75
Prev Close204.95
52W High (₹)219.00
Price205.00
52W Low (₹)53.80

Share Market Cap & Key Ratios Overview

M.Cap (₹)227.82 Cr
Div. Yield (%)0.00
PE Ratio23.57
Debt to Equity0.24
Price to Book1.35
Book Value46.91
EPS (TTM)8.70
Face Value10.00
ROE (%)28.72

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
ACCPL-STNSE
LTP
1W Low
1W High
Market cap (₹)
1856.7+19.4 (1.06%)
1832.20
1891.50
4,47,476Cr
9650+275 (2.93%)
9312.50
9740
2,54,764Cr
4949.5+109.5 (2.26%)
4848.50
5010
1,89,423Cr
1176.5+16.5 (1.42%)
1152.10
1185.70
1,16,658Cr
1409.1+14.6 (1.05%)
1364.50
1419
1,11,484Cr
2043.5+89.5 (4.58%)
1963.80
2055.30
1,09,943Cr
2496.5+195.8 (8.51%)
2303
2504.30
1,01,712Cr
1206.6+21.6 (1.82%)
1185
1222
1,01,005Cr
1725-9 (-0.52%)
1689.30
1740
99,253Cr
2105.5+22.5 (1.08%)
2080
2135
96,031Cr
205-5 (-2.38%)
197.60
214.95
228Cr

Key Highlights of Accretion Pharmaceuticals Ltd’s P&L

In 2026-03-31, Accretion Pharmaceuticals Ltd reported total revenue of ₹89.63Cr, compared with ₹57.38Cr in 2025-03-31, reflecting Accretion Pharmaceuticals Ltd turnover.

Depreciation was ₹1.21Cr and finance costs were ₹87.03Lakh in 2026-03-31

Profit Before Tax (PBT) has been ₹13.08Cr in 2026-03-31 as compared to ₹9.76Cr in 2025-03-31.

Net Profit (PAT) was ₹9.67Cr in 2026-03-31 compared with ₹6.79Cr in 2025-03-31.

Earnings per share (EPS) were ₹8.70 in 2026-03-31, compared with ₹8.32 in 2025-03-31.